Abbott Laboratories Common Stock (ABT)

About ABT

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic chol…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

122,000

Website

www.abbott.com

Fundamentals

1-day range

$112.91$115.66

Market cap

$186.81B

P/E (trailing)

35.52

P/E (forward)

18.90

EPS (trailing)

$3.11

Dividend yield

1.98%

Beta

0.57

Avg. volume

12.02M

Ex-dividend date

July 15, 2026

Dividend pay date

August 17, 2026

Forecasts

25 analyst ratings

Abbott Laboratories Common Stock Competitors

Chosen by industry and closest market cap.

• ABT

  Abbott Laboratories Common Stock

  $112.42

  ▲ 0.74%
  Market cap $186.81BP/E 35.52
  $81.97$137.49
• NVO

  Novo Nordisk A/S Common Stock

  $45.6

  ▼ 1.43%
  Market cap $203.55BP/E 11.40
  $224.25$409.95
• PFE

  Pfizer Inc. Common Stock

  $27.95

  ▼ 0.25%
  Market cap $149.33BP/E 35.19
  $23.58$28.75
• AZN

  AstraZeneca PLC Ordinary Shares

  $162.69

  ▼ 1.11%
  Market cap $249.78BP/E 23.44
  $10,784$15,730
• VRTX

  Vertex Pharmaceuticals Incorporated Common Stock

  $541.72

  ▼ 1.06%
  Market cap $122.68BP/E 30.70
  $374.17$555.69
• GSK

  GSK plc American Depositary Shares (Each representing two Ordinary Shares)

  $50.82

  ▲ 1.09%
  Market cap $105.65BP/E 15.53
  $1,441$2,282
• SNY

  Sanofi ADS

  $44.82

  ▼ 0.04%
  Market cap $104.60BP/E 16.24
  $71.25$91.15

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Best Dividend Aristocrats For September 2026
  SeekingAlpha · 8/28/2026
• FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
  Benzinga · 8/26/2026
• Abbott Laboratories (NYSE:ABT) Clears All Quality Investing Hurdles
  ChartMill · 8/26/2026
• SCHD And STK: A 3%+ Income Barbell
  SeekingAlpha · 8/26/2026
• FDA Authorizes Abbott's Libre Duo, First Device To Continuously Monitor Both Glucose And Ketones
  benzinga · 8/25/2026
• FDA Authorizes Abbott's Libre Duo, First Device To Continuously Monitor Both Glucose And Ketones
  Benzinga · 8/25/2026
• 10 Health Care Stocks Whale Activity In Today’s Session
  Benzinga · 8/25/2026
• The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products
  SeekingAlpha · 8/24/2026
• Best Dividend Kings: August 2026
  SeekingAlpha · 8/24/2026

• Robert B. Ford · August 25, 2026 · Option Exercise

  247.0K @ $59.94
• Robert B. Ford · August 25, 2026 · Option Exercise

  151.9K @ $44.4
• Robert B. Ford · August 25, 2026 · Sale

  180.3K @ $116.19
• Robert B. Ford · August 25, 2026 · Sale

  218.5K @ $115.57
• Louis H. Morrone · August 12, 2026 · I

  12 @ $107.99
• Louis H. Morrone · August 11, 2026 · Sale

  5.8K @ $109.83
• Nita Ahuja · June 30, 2026 · Grant

  347 @ $90.74
• Patricia Paola Gonzalez · June 30, 2026 · Grant

  363 @ $90.74
• Louis H. Morrone · June 30, 2026 · Tax Withholding

  269 @ $92.71
• Michael F. Roman · June 30, 2026 · Grant

  416 @ $90.74
• John G. Stratton · June 30, 2026 · Grant

  432 @ $90.74
• Kevin T. Conroy · June 30, 2026 · Grant

  231 @ $90.74
• John G. Stratton · May 7, 2026 · Buy

  2.0K @ $86.82
• Mary K. Moreland · April 28, 2026 · I

  5.3K @ $94.41
• Daniel J. Starks · April 27, 2026 · Buy

  10.0K @ $92.65

Institutional Ownership

March 31, 2026

Total shares held

1.30B

Total value held

$128.42B

Institutional holders

3061